Methyl 3,4-dihydro-2H-benzo[1,4]oxazine-6-carboxylate, 95.0%, 10g

4-Chloro-7-chlorosulfonyl-2,1,3-benzoxadiazole [Bifunctional Fluorescent Reagent]>97.0%(T)5g

1-Isopropyl-1H-indazol-5-amine, 95.0%, 5g

2,2,4,4,6,6-Hexamethyl-1,3,5-trithiane, 95.0%, 100g

tert-Butyl N-[(3S,4S)-4-hydroxypiperidin-3-yl]carbamate, 95%, 250mg

5-((1,4-Diazepan-1-yl)sulfonyl)isoquinolin-1(2H)-one, 95.0%, 100mg

1-((2,4,6-Triisopropylphenyl)sulfonyl)-1H-1,2,4-triazole, 95.0%, 25g

(3-(Ethoxycarbonyl)-5-fluorophenyl)boronic acid, 95.0%, 250mg

ethyl 5-(2,5-dimethoxyphenyl)-1H-pyrazole-3-carboxylate, 95.0%, 1g

2-(4-bromophenyl)-N,N-dimethylacetamide, 95.0%, 1g

Fmoc-Val-Cit-PAB-PNP>95.0%(HPLC)500mg

(E)-5-Dimethylamino-1-phenyl-pent-1-en-3-one; hydrochloride, 95.0%, 5g

(R)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid, 95.0%, 1g